Expression of phosphorylated (activated) receptors of vascular endothelial growth factor (VEGFR2/KDR) in colorectal cancer

Expression of phosphorylated (activated) receptors of vascular endothelial growth factor (VEGFR2/KDR) in colorectal cancer

Dades bibliogràfiques
Autors principals:	Giatromanolaki, A, Koukourakis, M, Harris, A, Gatter, K, Stamos, H, Sivridis, E
Format:	Journal article
Publicat:	2007

Ítems similars

Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
per: Giatromanolaki, A, et al.
Publicat: (2008)

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.
per: Giatromanolaki, A, et al.
Publicat: (2012)

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival
per: Giatromanolaki, A, et al.
Publicat: (2011)

Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
per: Giatromanolaki, A, et al.
Publicat: (2007)

Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
per: Koukourakis, M, et al.
Publicat: (2006)

Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective
per: Siddharth J. Modi, et al.
Publicat: (2019-06-01)

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
per: Giatromanolaki, A, et al.
Publicat: (2003)

Phosphorylated VEGFR-2 (pVEFGR-2/pKDR) is over-expressed in and translocates to the nucleus in acute leukemias: Analyses using a novel pKDR antibody.
per: Zhang, Y, et al.
Publicat: (2003)

Vascular endothelial growth factor expression in lung cancer.
per: O'Byrne, K, et al.
Publicat: (1998)

Phosphorylated KDR expression in acute leukaemia.
per: Watt, S, et al.
Publicat: (2002)

Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas.
per: Giatromanolaki, A, et al.
Publicat: (2010)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
per: Koukourakis, M, et al.
Publicat: (2010)

Phosphorylated KDR can be located in the nucleus of neoplastic cells.
per: Blazquez, C, et al.
Publicat: (2006)

The expression of phosphorylated KDR in haematological malignancies
per: Pillai, G, et al.
Publicat: (2003)

Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression.
per: Giatromanolaki, A, et al.
Publicat: (2006)

Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
per: Koukourakis, M, et al.
Publicat: (2006)

Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer.
per: Giatromanolaki, A, et al.
Publicat: (2002)

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
per: Giatromanolaki, A, et al.
Publicat: (2008)

Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.
per: Koukourakis, M, et al.
Publicat: (2005)

High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).
per: Koukourakis, M, et al.
Publicat: (2013)

Evolutionary Differences in the Vegf/Vegfr Code Reveal Organotypic Roles for the Endothelial Cell Receptor Kdr in Developmental Lymphangiogenesis
per: Adam J. Vogrin, et al.
Publicat: (2019-08-01)

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
per: Sivridis, E, et al.
Publicat: (2002)

Inclusion of vasculature-related variables in the Dukes staging system of colon cancer.
per: Koukourakis, M, et al.
Publicat: (2005)

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.
per: Sivridis, E, et al.
Publicat: (2002)

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials.
per: Giatromanolaki, A, et al.
Publicat: (2012)

BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer.
per: Giatromanolaki, A, et al.
Publicat: (2004)

EXPRESSION OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS RECEPTORS (VEGFR-1 AND VEGFR-2) IN PRIMARY TUMOR CELLS IN PATIENTS WITH RENAL CANCER
per: D. A. Khochenkov, et al.
Publicat: (2021-08-01)

The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study.
per: Stewart, M, et al.
Publicat: (2003)

Autophagy and hypoxia in colonic adenomas related to aggressive features.
per: Giatromanolaki, A, et al.
Publicat: (2013)

Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
per: Nichole E. M. Kaufman, et al.
Publicat: (2021-02-01)

An Investigation of Vascular Endothelial Growth Factor (VEGFR-1 and VEGFR-2) in Burn Wound Healing
per: L Abdulazeem, et al.
Publicat: (2022-04-01)

Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers.
per: Smith, N, et al.
Publicat: (2010)

Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
per: Giatromanolaki, A, et al.
Publicat: (1998)

Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
per: Giatromanolaki, A, et al.
Publicat: (2006)

Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.
per: Giatromanolaki, A, et al.
Publicat: (2008)

Pyruvate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression in Non Small Cell Lung Cancer and Tumor-Associated Stroma
per: Michael I. Koukourakis, et al.
Publicat: (2005-01-01)

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus
per: Ewa Robak, et al.
Publicat: (2003-01-01)

Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
per: Ozen Fatma Zeynep, et al.
Publicat: (2024-01-01)

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
per: Koukourakis, M, et al.
Publicat: (2003)

Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas.
per: Giatromanolaki, A, et al.
Publicat: (2013)